https://canceradvocacy.org/wp-content/uploads/2014/06/FacebookProfile3.png
280
280
actualizedevs
https://canceradvocacy.org/wp-content/uploads/CancerNation_Logo_Stacked_TwoColor.svg
actualizedevs2012-03-15 09:44:302012-03-15 09:44:30NCCS and CLC Comments on PCORI research prioritiesNCCS is now Cancer Nation. Find out more about our next chapter. Join Us
News
https://canceradvocacy.org/wp-content/uploads/2014/06/FacebookProfile3.png
280
280
actualizedevs
https://canceradvocacy.org/wp-content/uploads/CancerNation_Logo_Stacked_TwoColor.svg
actualizedevs2012-03-15 09:44:302012-03-15 09:44:30NCCS and CLC Comments on PCORI research priorities
Beating the odds
I have to admit it. Even today, I find interpreting statistics for patients very difficult; not because I don't understand the concept…

Survival at a cost: common cancer treatment carries huge risks
While the number of cancer survivors has tripled since the 1970s and continues to grow decades later, the cost of that survival for…

Chemotherapy can impair cognition more than two decades later
More than 20 years after treatment, breast cancer patients who received adjuvant chemotherapy exhibited cognitive deficits compared…

FDA approves new suppliers for hard-to-find cancer drugs
New supplies of two currently hard-to-find cancer drugs are on the way, according to the FDA.
As Dow Jones Newswires reports, the…

Sebelius says leukemia-drug shortage will be resolved within two weeks
Federal health officials said there will be enough supply of a children’s leukemia drug released in the next couple of weeks to alleviate…

Most women with cancer want a role in making decisions
About two-thirds of women diagnosed with early stage breast cancer want to take part in making decisions about their treatment, according…
Supply of a cancer drug may run out within weeks
A crucial medicine to treat childhood leukemia is in such short supply that hospitals across the country may exhaust their stores within…
